Kymera Therapeutics Inc
Closed
SectorHealthcare
112.93 -1.19
Overview
Share price change
24h
Min
112.31
Max
113.01
Income | 18M -69M |
|---|---|
Sales | 32M 34M |
EPS | -0.71 |
Profit margin | -201.467 |
Employees | 253 |
EBITDA | 18M -67M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +12.47% upside |
Next Earnings | 11 sie 2026 |
|---|
Market Cap | 1.9B 9B |
|---|---|
Previous open | 114.12 |
Previous close | 112.93 |
News Sentiment
By Acuity
50%
50%
156 / 342 Ranking in Healthcare
Kymera Therapeutics Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Kymera Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 127.67 USD 12.47%
High 155 USD
Low 106 USD
Based on 14 Wall Street analysts offering 12 month price targets forKymera Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$